Irina Nikolaevna Kadiyala

USPTO Granted Patents = 19 (Patent Applications = 20)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 16)

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 364(Granted Patents)

Location History:

Baltimore, MD (US) (2002 - 2004)
South Easton, MA (US) (2010)
Newton, MA (US) (2012 - 2022)

Company Filing History:

17 out of 1,152

Vertex Pharmaceuticals, Inc.

patents

5 out of 40

Biomed Valley Discoveries, Inc.

patents

2 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187698 - Crystalline forms of CHClNO (2025-01-07),

2. 11390600 - Crystalline forms of CHClNO (2022-07-19),

3. 11052075 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2021-07-06),

4. 10738027 - Crystalline forms of CHClNO (2020-08-11),

5. 10716789 - Co-crystals and pharmaceutical compositions comprising the same (2020-07-21),

6. 10183927 - [object Object] (2019-01-22),

7. 10076513 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2018-09-18),

8. 10058546 - Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof (2018-08-28),

9. 10039761 - Co-crystals and pharmaceutical compositions comprising the same (2018-08-07),

10. 9676746 - [object Object] (2017-06-13),

11. 9241934 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2016-01-26),

12. 9012496 - Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof (2015-04-21),

13. 8759353 - Co-crystals and pharmaceutical compositions comprising the same (2014-06-24),

14. 8563593 - Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2013-10-22),

15. 8552034 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2013-10-08),

Title: The Innovative Mind of Irina Nikolaevna Kadiyala

Introduction: Irina Nikolaevna Kadiyala is a pioneering inventor based in Newton, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Irina Nikolaevna Kadiyala holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Irina Nikolaevna Kadiyala has worked with prestigious research institutions and leading companies to develop cutting-edge technologies that have had a significant impact on society.

Collaborations: Throughout her career, Irina Nikolaevna Kadiyala has collaborated with top scientists, engineers, and innovators, fostering a culture of innovation and excellence in all her projects.

Conclusion: Irina Nikolaevna Kadiyala's relentless pursuit of innovation and her passion for creating solutions to complex challenges make her a true trailblazer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.